Skip to main content

Free Content Resistance to anti-tuberculosis medications in the Horn of Africa [Notes from the field]

Download Article:
(PDF 218.7 kb)
We performed drug susceptibility testing among chronic patients hospitalised in the tuberculosis (TB) referral centre of the capital of Djibouti. Among 36 patients tested, 27 had multidrug-resistant TB and four had extensively drug-resistant TB. National guidelines must be revised urgently and the administration of second-line TB medications strictly controlled.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Djibouti; Horn of Africa; MDR-TB; XDR-TB; tuberculosis

Document Type: Short Communication

Affiliations: 1: Catalan Association for the Control of Tuberculosis in the Third World (ACTMON), Barcelona, Spain; and Infectious Disease Department, Hôpital Général Peltier, Djibouti 2: Department of Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autonoma, Barcelona, Spain

Publication date: 01 March 2011

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more